Fieldpoint Private Securities, LLC Spring Works Therapeutics, Inc. Transaction History
Fieldpoint Private Securities, LLC
- $344 Million
- Q2 2022
A detailed history of Fieldpoint Private Securities, LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Fieldpoint Private Securities, LLC holds 1,615 shares of SWTX stock, worth $75,888. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,615
Previous 1,619
0.25%
Holding current value
$75,888
Previous $91,000
56.04%
% of portfolio
0.01%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding SWTX
# of Institutions
24Shares Held
7.39MCall Options Held
23KPut Options Held
0-
Black Rock Inc. New York, NY5.62MShares$264 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V81.06MShares$49.9 Million0.03% of portfolio
-
Eagle Asset Management Inc St Petersburg, FL273KShares$12.9 Million0.05% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL184KShares$8.63 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V859.2KShares$2.78 Million0.0% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.93B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...